<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01873560</url>
  </required_header>
  <id_info>
    <org_study_id>IB-2-1306-020</org_study_id>
    <nct_id>NCT01873560</nct_id>
  </id_info>
  <brief_title>Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention</brief_title>
  <acronym>PERSPECTIVE</acronym>
  <official_title>Influence of Fractional Flow Reserve (FFR) on the Clinical OutcomEs of PERcutaneouS Coronary Intervention (PCI): A ProspECTIVE, Multicenter FFR Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ulsan University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kangdong Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Busan Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Myongji Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chungbuk National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hanyang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dong-A University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gyeongsang National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fractional flow reserve (FFR) is a physiologic index for the determination of
      ischemia-causing coronary stenosis as well as drug eluting stent (DES) optimization, even
      multiple anatomic imaging parameters have been widely used in clinical practice for the
      assessment of optimal stent procedure. Prognostic value between post-stent FFR (FFRpost) have
      been rarely evaluated in patient treated with DES. This multicentre, prospective registry was
      aimed to evaluate influence of physiologic parameters on the clinical outcome after DES
      implantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who diagnosed obstructive coronary artery disease and treated by DES with FFR
      examination would be enrolled, consecutively. FFR measurement would be required at the
      baseline and at the end of index PCI procedure. PCI procedure would be performed upon local
      routine. Any available DES could be used. Informed consent should be obtained and protocol
      should be approved by each collaborator's institutional review board (IRB). Web-based
      electronic-case record form (CRF) system will be used for collecting data. All data will be
      handled and analyzed by blind fashion at independent core lab. Patient will be followed-up at
      each collaborator's hospital at least 2 year after index procedure. Any adverse event will be
      reported and addressed immediately by appropriate medical treatment to protect patient.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Target vessel related major adverse cardiovascular event rate</measure>
    <time_frame>2 years after index procedure</time_frame>
    <description>During two-year follow-up period, target vessel related major adverse cardiovascular event (composite of any cardiac death, non-fatal myocardial infarction, any target vessel related revascularization) will be evaluated. Target vessel will be defined as the treated vessel with DES which assessed by post-stent FFR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical, angiographic and physiologic predictors for MACE</measure>
    <time_frame>2 years after index procedure</time_frame>
    <description>Clinical, angiographic and physiologic predictors for target vessel related MACE by univariate and multivariate analysis will be performed.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Intravascular ultrasound (IVUS) derived predictors for post-stent FFR and MACE</measure>
    <time_frame>2 years after index procedure</time_frame>
    <description>In patient who performed IVUS examination, IVUS derived parameters will be evaluated for the prediction of post-stent FFR and MACE</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1250</enrollment>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>FFRpost</arm_group_label>
    <description>FFRpost &lt;0.9 group the patient with FFR values less than 0.9 after DES procedure
FFRpost ≥0.9 group the patient with FFR values greater than 0.9 after DES procedure</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who diagnosed obstructive coronary artery disease and treated by DES with FFR
        examination at the index procedure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  any patient meets eligible criteria who underwent PCI with DES followed by FFR
             measurement at the index procedure

          -  patient who provide informed consent

        Exclusion Criteria:

          -  culprit vessel of acute coronary syndrome with regional wall motion abnormality

          -  visible thrombus of target vessel segment

          -  failed achieving TIMI 3 flow at the end of PCI

          -  left ventricular ejection fraction &lt;30%

          -  primary myocardial or valvular heart disease.

          -  documented evidence of vasospastic angina

          -  pregnant women

          -  in patient whose life expectancy less than 2 years

          -  chronic renal failure s-Cr &gt; 2.5mg/dl
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joon Hyung Doh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje Univesity Ilsan Paik Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bon-Kwon Koo</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inje University Ilsan Paik Hospital</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi</state>
        <zip>411-706</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Escaned J, Tsurumi Y, Akasaka T, Samady H, De Bruyne B; Fractional Flow Reserve (FFR) Post-Stent Registry Investigators. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002 Jun 25;105(25):2950-4.</citation>
    <PMID>12081986</PMID>
  </reference>
  <reference>
    <citation>Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009 Jan 15;360(3):213-24. doi: 10.1056/NEJMoa0807611.</citation>
    <PMID>19144937</PMID>
  </reference>
  <reference>
    <citation>Nam CW, Hur SH, Cho YK, Park HS, Yoon HJ, Kim H, Chung IS, Kim YN, Kim KB, Doh JH, Koo BK, Tahk SJ, Fearon WF. Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes. Am J Cardiol. 2011 Jun 15;107(12):1763-7. doi: 10.1016/j.amjcard.2011.02.329. Epub 2011 Apr 8.</citation>
    <PMID>21481828</PMID>
  </reference>
  <reference>
    <citation>Samady H, McDaniel M, Veledar E, De Bruyne B, Pijls NH, Fearon WF, Vaccarino V. Baseline fractional flow reserve and stent diameter predict optimal post-stent fractional flow reserve and major adverse cardiac events after bare-metal stent deployment. JACC Cardiovasc Interv. 2009 Apr;2(4):357-63. doi: 10.1016/j.jcin.2009.01.008.</citation>
    <PMID>19463450</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2013</study_first_submitted>
  <study_first_submitted_qc>June 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2013</study_first_posted>
  <last_update_submitted>September 3, 2017</last_update_submitted>
  <last_update_submitted_qc>September 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Joon Hyung Doh</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>fractional flow reserve</keyword>
  <keyword>drug eluting stent</keyword>
  <keyword>coronary atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

